| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/08/2003 | EP1272640A2 3714, 16742, 23546, and 13887 novel protein kinase molecules and uses therefor |
| 01/08/2003 | EP1272639A2 Genes encoding denitrification enzymes |
| 01/08/2003 | EP1272638A2 Drug metabolizing enzymes |
| 01/08/2003 | EP1272637A1 A METHOD FOR SCREENING FOR AUTOIMMUNE DISEASE BY IDENTIFYING POLYMORPHISMS IN IL-12 p40 |
| 01/08/2003 | EP1272636A2 A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 01/08/2003 | EP1272635A1 Cryptic-like secreted protein |
| 01/08/2003 | EP1272634A1 Human ion channel protein and polynucleotides encoding the same |
| 01/08/2003 | EP1272633A2 Compositions and methods for dendritic cell-based immunotherapy |
| 01/08/2003 | EP1272632A1 Dna immunization vectors |
| 01/08/2003 | EP1272631A2 Regulation of human hm74-like g protein coupled receptor |
| 01/08/2003 | EP1272630A2 Methods and compositions for rna interference |
| 01/08/2003 | EP1272629A1 Genetic silencing |
| 01/08/2003 | EP1272628A2 Method of nucleic acid recovery |
| 01/08/2003 | EP1272627A2 Method and apparatus for plasmid recovery involving ultrafiltration |
| 01/08/2003 | EP1272626A2 Methods for in vivo diversification of single genes |
| 01/08/2003 | EP1272625A2 CpG REDUCED PLASMIDS AND VIRAL VECTORS |
| 01/08/2003 | EP1272624A1 A process for the production of human interferon alpha from genetically engineered yeast |
| 01/08/2003 | EP1272623A2 Novel subtilase enzymes having an improved wash performance on egg stains |
| 01/08/2003 | EP1272621A1 Plant anthocyanidin rutinoside aromatic acyl transferases |
| 01/08/2003 | EP1272615A2 Osteocalcin promoter directed adenovirus replicaton for therapy |
| 01/08/2003 | EP1272614A1 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 01/08/2003 | EP1272612A1 Renilla reniformis green fluorescent protein and mutants thereof |
| 01/08/2003 | EP1272610A1 Mutant bank |
| 01/08/2003 | EP1272608A2 REGENERATION AND GENETIC TRANSFORMATION OF i ACACIA MANGIUM /i |
| 01/08/2003 | EP1272527A2 Anti-d monoclonal antibodies |
| 01/08/2003 | EP1272526A1 Enhancement of antibody-mediated immune responses |
| 01/08/2003 | EP1272523A1 Human emr2, a g-protein coupled receptor from the egf-tm7 family |
| 01/08/2003 | EP1272522A1 Selectable marker genes |
| 01/08/2003 | EP1272520A2 Gpcr-proteins and nucleic acids encoding same |
| 01/08/2003 | EP1272519A2 Regulation of human neuropeptide y-like g protein-coupled receptor |
| 01/08/2003 | EP1272518A2 Cd20/ige-receptor like molecules and uses thereof |
| 01/08/2003 | EP1272517A2 Multiprotein-complexes comprising a nmda receptor and uses thereof |
| 01/08/2003 | EP1272514A1 Dna encoding human vanilloid receptor vr3 |
| 01/08/2003 | EP1272513A2 Neurogenic compositions and methods |
| 01/08/2003 | EP1272511A2 Molecules associated with human reproduction |
| 01/08/2003 | EP1272508A2 Methods for producing recombinant proteins |
| 01/08/2003 | EP1272506A1 Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis |
| 01/08/2003 | EP1272503A1 DNA MOLECULES ENCODING L-GLUTAMATE-GATED CHLORIDE CHANNELS FROM i RHIPICEPHALUS SANGUINEUS /i |
| 01/08/2003 | EP1272502A2 Dna molecules and polypeptides of pseudomonas syringae hrp pathogenicity island and their uses |
| 01/08/2003 | EP1272222A2 Compositions for drug delivery |
| 01/08/2003 | EP1272221A2 Peptide conjugates for drug delivery |
| 01/08/2003 | EP1272208A2 Use of vegf and homologues to treat neuron disorders |
| 01/08/2003 | EP1272206A1 Non-mammalian gnrh analogs and uses thereof in tumor cell growth regulation and cancer therapy |
| 01/08/2003 | EP1272205A1 Sialoadhesin factor-2 antibodies |
| 01/08/2003 | EP1272030A1 Methods for sexing non-human mammals |
| 01/08/2003 | EP1179074A4 Novel genes encoding wheat starch synthases and uses therefor |
| 01/08/2003 | EP1151093A4 Isolation of nucleic acid molecules |
| 01/08/2003 | EP1080189A4 Compositions and methods for the synthesis of fatty acids, their derivatives and downstream products |
| 01/08/2003 | EP1005358B1 Use of a neurturin protein product for preventing and treating hearing loss |
| 01/08/2003 | EP1001677A4 A novel method for treating epidermal or dermal conditions |
| 01/08/2003 | EP0996727B1 Gene conferring obese phenotype |
| 01/08/2003 | EP0974111B1 Apparatus and method for automated protein design |
| 01/08/2003 | EP0934526B1 Methods and means for selecting peptides and proteins having specific affinity for a target |
| 01/08/2003 | EP0929579B1 Monoclonal antibodies against a human act and serine protease complex |
| 01/08/2003 | EP0817646B1 Methods of treating inflammation and compositions therefor |
| 01/08/2003 | EP0805857A4 Method for generating proteolytic enzymes specific against a selected peptide sequence |
| 01/08/2003 | EP0751996B1 Luciferases |
| 01/08/2003 | EP0728194B1 In situ modification and manipulation of stem cells of the central nervous system |
| 01/08/2003 | EP0607309B1 The regulation of systemic immune responses utilizing cytokines and antigens |
| 01/08/2003 | CN1390264A Long oligonucleotide arrays |
| 01/08/2003 | CN1390263A High throughput assay system |
| 01/08/2003 | CN1390262A Transgenic plants exhibiting resistance to a broad spectrum of pathogens |
| 01/08/2003 | CN1390261A GMP synthetase derived from plants |
| 01/08/2003 | CN1390260A Expression of proteins in genetically modified fungi |
| 01/08/2003 | CN1390259A Lepidopteran-active bacillus thuringiensis-endotoxin compositions and methods of use |
| 01/08/2003 | CN1390258A Factor IX/factor IXa antibodies and antibody derivatives |
| 01/08/2003 | CN1390257A Transfer compounds, the production and the use thereof |
| 01/08/2003 | CN1390256A Novel protein and DNA thereof |
| 01/08/2003 | CN1390255A Use of disease-associated gene |
| 01/08/2003 | CN1390254A A method for isolating phenotype switch molecules and phenotype related gene batteries |
| 01/08/2003 | CN1390253A High order nucleic acid based structures |
| 01/08/2003 | CN1390252A Fungamyl-like alpha-amylase variants |
| 01/08/2003 | CN1390233A Antitumor antibodies, proteins, and uses thereof |
| 01/08/2003 | CN1390232A Human beta-secretase enzyme, inhibitor, and its composition and use |
| 01/08/2003 | CN1390229A Methods of DNA purification and purified DNA |
| 01/08/2003 | CN1390141A Nucleic acid-containing complex |
| 01/08/2003 | CN1390140A Method for linking molecular substances |
| 01/08/2003 | CN1390089A Transgenic fiber producing plants with increased expression of sucrose phosphate synthase |
| 01/08/2003 | CN1389571A Detecting gene and detecting kit for wilting virus of kidney bean |
| 01/08/2003 | CN1389268A Hepatitis B DNA vaccine |
| 01/08/2003 | CN1098103C Pharmaceutical use of sympathetic human white-cell interferon |
| 01/08/2003 | CN1098029C Pollen-based transformation system using solid culture media |
| 01/08/2003 | CA2415458A1 Two coloured fluorimetric protease assay |
| 01/07/2003 | WO2002004664A2 Genes comprising coding mononucleotide microsatellites or dinucleotide microsatellites that can be isolated from tumour cells |
| 01/07/2003 | USRE37958 DNA sequence coding for protein C |
| 01/07/2003 | US6505180 Information encoding and retrieval through synthetic genes |
| 01/07/2003 | US6505126 Identifying nucleic acids and polypeptides |
| 01/07/2003 | US6504085 A method for extraction of heterologous protein from plant seed comprises extracting the germ portion of the seed and extracting and purifying the protein from the germ. Enhanced expression in the germ is provided, and allows for improved |
| 01/07/2003 | US6504084 Maize NPR1 polynucleotides and methods of use |
| 01/07/2003 | US6504083 Maize Gos-2 promoters |
| 01/07/2003 | US6504082 Ecdysone receptors and methods for their use |
| 01/07/2003 | US6504081 Methods and uses for transposon-based gene targeting |
| 01/07/2003 | US6504080 Transgenic animal model for neurodegenerative disorders |
| 01/07/2003 | US6504024 Useful as substrates for polymerase enzymes; used in preparing fluorescently-labeled nucleotides useful as substrates for thermostable polymerases |
| 01/07/2003 | US6504023 DNA encoding type II IL-1 receptors |
| 01/07/2003 | US6504022 Human bad polypeptides, encoding nucleic acids and methods of use |
| 01/07/2003 | US6504021 Contacting with porous cation and anion exchange resins; does not bind or remove the DNA of interest |
| 01/07/2003 | US6504013 Canine allergy therapeutic recombinant chimeric anti-IgE monoclonal antibody |
| 01/07/2003 | US6504011 Recombinantly produced serum albumin is purified in a series of steps, optionally by incubation with an anion-exchange adsorbent, followed by affinity chromatography employing a hydrophobic solid phase and using a water-soluble lipid anion |
| 01/07/2003 | US6504009 Transcriptional regulator |